Cover Image

Fabrication and Optimization of a Silodosin In Situ-Forming PLGA Implants for the Treatment of Benign Prostatic Hyperplasia: In Vitro and In Vivo Study

<b>Objectives:</b> Lower urinary tract symptoms (LUTSs) related to benign prostatic hyperplasia (BPH) are common in older men, and alpha-adrenoceptor blockers continue to be a key part of managing these symptoms. This study aimed to formulate injectable poly (lactic-co-glycolic acid) (PL...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rabab A. Husseini (Author), Tarek M. Ibrahim (Author), Eslam Hamed (Author), Eman Gomaa (Author), Mennatullah M. Faisal (Author), Ghadeer Wan (Author), Manna Amin (Author), Ali M. Alkolaib (Author), Dina M. Abdelnabi (Author)
Format:	Book
Published:	MDPI AG, 2024-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Silodosin in the treatment of benign prostatic hyperplasia
by: Maxime Rossi, et al.
Published: (2010)

Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study
by: Hiroshi Takahashi, et al.
Published: (2019)

Development of depot PLGA-based in-situ implant of Linagliptin: Sustained release and glycemic control
by: Eman Gomaa, et al.
Published: (2023)

Fabrication and physicochemical characterisation of novel pimozide loaded PLGA nanoparticles
by: Ahmed M Faheem, et al.
Published: (2019)

Evolving Role of Silodosin for the Treatment of Urological Disorders – A Narrative Review
by: Jindan L, et al.
Published: (2022)

Exploring a Bioequivalence Failure for Silodosin Products Due to Disintegrant Excipients
by: Isabel González-Álvarez, et al.
Published: (2022)

Bimodal Release Two-In-One Clonazepam Matrix Lozenge Tablets for Managing Anxiety-Related Disorders: Formulation, Optimization and In Vivo Evaluation
by: Eman Gomaa, et al.
Published: (2022)

Injectable In-Situ Forming Depot Based on PLGA and PLGA-PEG-PLGA for Sustained-Release of Risperidone: In Vitro Evaluation and Pharmacokinetics in Rabbits
by: Seyedeh Nesa Rezaeian Shiadeh, et al.
Published: (2023)

Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration
by: Mozan Hassan, et al.
Published: (2024)

THE FACTORS ASSOCIATED WITH THE INCIDENCE OF BENIGN PROSTATIC HYPERPLASIA
by: sukron sukron
Published: (2022)

Investigation of Alogliptin-Loaded In Situ Gel Implants by 2<sup>3</sup> Factorial Design with Glycemic Assessment in Rats
by: Tarek M. Ibrahim, et al.
Published: (2022)

Immunohistochemical features of benign endometrial hyperplasia in premenopausal women
by: Н. М. Рожковська, et al.
Published: (2020)

Age and Prostatic Volume: The Prognosis for Benign Prostatic Hyperplasia
by: Dr. Afsheen Khan, et al.
Published: (2024)

Finasteride therapy in a dog with benign prostatic hyperplasia
by: Hyejin Kim
Published: (2022)

Effect of rape flower on benign prostatic hyperplasia in rats
by: Song-Chan Han, et al.
Published: (2022)

Protective effects of the selective alpha1A-adrenoceptor antagonist silodosin against cyclophosphamide-induced cystitis in rats
by: Nanxi Liu, et al.
Published: (2016)

Burst Release from In Situ Forming PLGA-Based Implants: 12 Effectors and Ways of Correction
by: Elena O. Bakhrushina, et al.
Published: (2024)

Microporation-Mediated Transdermal Delivery of In Situ Gel Incorporating Etodolac-Loaded PLGA Nanoparticles for Management of Rheumatoid Arthritis
by: Heba M. El Sorogy, et al.
Published: (2024)

Safety profile of colocasia esculenta tuber extracts in benign prostate hyperplasia
by: Deusdedit Tusubira, et al.
Published: (2023)

Xanthogranulomatous prostatitis with benign prostatic hyperplasia: A rare combination
by: Navjot Grewal, et al.
Published: (2017)

Finasteride in the treatment of patients with benign prostatic hyperplasia: a review
by: Angela B Smith, et al.
Published: (2009)

Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia
by: Masumori N
Published: (2011)

EFFECT OF BENIGN PROSTATIC HYPERPLASIA ON MORPHOLOGICAL CHANGES IN THE WALL OF THE BLADDER
by: O.V. Shmulichenko
Published: (2017)

Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia
by: Yu Tong, et al.
Published: (2020)

Association of receptor expression with prostate volume in benign prostatic hyperplasia
by: Karli Sreenivasulu, et al.
Published: (2019)

Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats
by: Ehsan Shabani, et al.
Published: (2021)

Aescin Protects against Experimental Benign Prostatic Hyperplasia and Preserves Prostate Histomorphology in Rats via Suppression of Inflammatory Cytokines and COX-2
by: Mohamed Raafat, et al.
Published: (2022)

Acral lentiginous melanoma in situ with a characteristically benign dermatoscopic parallel-furrow pattern
by: Shifa Akhtar, BS, et al.
Published: (2022)

Microfluidic-based fabrication and characterization of drug-loaded PLGA magnetic microspheres with tunable shell thickness
by: Chunpeng He, et al.
Published: (2021)

Effect of nocturia on quality of life among clients with benign prostatic hyperplasia
by: Susamma Varughese, et al.
Published: (2021)

Two Cases of Benign Prostatic Hyperplasia with Bee Venom Pharmacopunture Therapy
by: Gang Hyeon Min, et al.
Published: (2008)

Light-controlled calcium signalling in prostate cancer and benign prostatic hyperplasia
by: Vipin Sharma, et al.
Published: (2020)

Manual flowmetry in the clinical and therapeutic evaluation of patients with benign prostatic hyperplasia
by: Aurelio León Estrda
Published: (2022)

Angiolymphoid hyperplasia with eosinophilia: A rare benign vascular tumor of breast
by: Neelima Tirumalasetti
Published: (2013)

Cordycepin Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats via Modulation of AMPK and AKT Activation
by: Abdulmohsin J. Alamoudi, et al.
Published: (2022)

PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
by: N. A. Avxentyev, et al.
Published: (2016)

Effects of pumpkin on benign prostatic hyperplasia: a systematic review and meta- analysis
by: Thamali Rangika, et al.
Published: (2023)

A review of therapeutic exercise strategies for prostate cancer and benign prostate hyperplasia
by: Jin Hwan Yoon
Published: (2020)

Omentin-1 inhibits the development of benign prostatic hyperplasia by attenuating local inflammation
by: Yi-Yi Wang, et al.
Published: (2024)

Endovideoscopic simple prostatectomy via extraperitoneal research as treatment of benign prostatic hyperplasia
by: Stanislav N. Volkov, et al.
Published: (2023)